Effect of acute exercise and hypoxia on markers of systemic and mucosal immunity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1439-6327
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of acute exercise and hypoxia on markers of systemic and mucosal immunity ; volume:116 ; number:6 ; day:29 ; month:4 ; year:2016 ; pages:1219-1229 ; date:6.2016
European journal of applied physiology ; 116, Heft 6 (29.4.2016), 1219-1229, 6.2016
- Urheber
-
Svendsen, Ida S.
- Beteiligte Personen und Organisationen
-
Hem, Erlend
Gleeson, Michael
SpringerLink (Online service)
- DOI
-
10.1007/s00421-016-3380-4
- URN
-
urn:nbn:de:1111-2016052320070
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Svendsen, Ida S.
- Hem, Erlend
- Gleeson, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2
Mucosal MCMV infection of neonates : pathogenicity and antiviral immunity
Harnessing mucosal immunity against respiratory viruses using adenoviral vectors encoding cytokines/chemokines as mucosal adjuvants
Alveolar hypoxia, alveolar macrophages, and systemic inflammation
Ocular mucosal homeostasis of teleost fish provides insight into the coevolution between microbiome and mucosal immunity
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2
Mucosal MCMV infection of neonates : pathogenicity and antiviral immunity
Harnessing mucosal immunity against respiratory viruses using adenoviral vectors encoding cytokines/chemokines as mucosal adjuvants
Alveolar hypoxia, alveolar macrophages, and systemic inflammation
Ocular mucosal homeostasis of teleost fish provides insight into the coevolution between microbiome and mucosal immunity
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2
Mucosal MCMV infection of neonates : pathogenicity and antiviral immunity
Harnessing mucosal immunity against respiratory viruses using adenoviral vectors encoding cytokines/chemokines as mucosal adjuvants
Alveolar hypoxia, alveolar macrophages, and systemic inflammation